Status: Closed
Know more about this business than we do? Cool! Please submit any corrections or missing details you may have.
Help us make it rightLa Jolla Pharmaceutical Company is a biotechnology company engaged in the development of therapeutics for antibody-mediated autoimmune diseases afflicting several million people in the United States and Europe. The company is developing riquent for the treatment of patients with lupus kidney disease, a leading cause of sickness and death in lupus patients. The company is also developing small...
La Jolla Pharmaceutical Company is dedicated to the development of treatments that significantly improve outcomes in patients with life-threatening diseases. Our current efforts focus on the clinical evaluation of GCS-100, a galectin antagonist, as a treatment for chronic organ disease and LJPC-501, an antagonist of the renin-angiotensin pathway, as a treatment for hepatorenal syndrome, a...
La Jolla Pharmaceutical operates in the business service industry.
La Jolla Pharmaceutical Company was founded in 1989. La Jolla Pharmaceutical Company specializes in Biological Research.
La Jolla Pharmaceutical Company is a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapeutics for chronic organ failure and cancer. GCS-100, the Company’s lead product candidate, is a first-in-class inhibitor of galectin-3, a novel molecular target implicated in chronic organ failure and cancer. LJPC-501, the Company’s second product...
If you don't see your business listed on YellowBot, please add your business listing.
YellowBot wants to get your input! If you have a comment, find a bug or think of something neat we should do, let us know.
© 2007-2024 Solfo, Inc. – All rights reserved